the influence of an 8-day therapy with rifampicin ( 600 mg daily ) was studied on antipyrine plasma clearance and metabolite formation in seven patients with tuberculosis ( age 18-79 years ) , who were also treated with isoniazid and pyrazinamide .
C0035608
rifampicin
C0041296
tuberculosis